Treatment of acute Old World cutaneous leishmaniasis: a systematic review of the randomized controlled trials.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of American Academy of Dermatology

• Publication date

  2007-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JAAD.2007.01.016PMID 17337090
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current scenario of drug development for leishmaniasis.

  2006cited by this paper
• Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites

  2006cited by this paper
• Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis

  2006cited by this paper
• Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis

  2006cited by this paper
• Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial.

  2006cited by this paper
• Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo‐controlled, randomized clinical trial

  2006cited by this paper
• A COMPARISON BETWEEN INTRALESIONAL HYPERTONIC SODIUM CHLORIDE SOLUTION AND MEGLUMINE ANTIMONIATE (GLUCANTIME) INJECTIONS IN THE TREATMENT OF CUTANEOUS LEISHMANIASIS

  2005cited by this paper
• Intralesional injection of 2% zinc sulfate solution in the treatment of acute old world cutaneous leishmaniasis: a randomized, double-blind, controlled clinical trial.

  2005cited by this paper
• Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004.

  2005cited by this paper
• Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.

  2005cited by this paper
• Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis.

  2005cited by this paper
• Leishmania tropica in northern Israel: a clinical overview of an emerging focus.

  2005cited by this paper
• Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran

  2005cited by this paper
• Advances in leishmaniasis.

  2005cited by this paper
• COMPARISON OF EFFICACY OF ORAL FLUCONAZOLE WITH INTRAMUSCULAR GLUCANTIME IN PATIENTS WITH ACUTE CUTANEOUS LEISHMANIASIS

  2005cited by this paper
• Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial.

  2005cited by this paper
• A randomized, double‐blind, placebo‐controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis

  2005cited by this paper
• Evaluation of CO laser efficacy in the treatment of cutaneous leishmaniasis.

  2004cited by this paper
• Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime®) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime®) alone for the treatment of cutaneous leishmaniasis

  2004cited by this paper
• Evaluation of CO2 laser efficacy in the treatment of cutaneous leishmaniasis

  2004cited by this paper
• Leishmaniasis: current situation and new perspectives.

  2004cited by this paper
• Comparison of Intralesionally Injected Zinc Sulfate with Meglumine Antimoniate in the Treatment of Acute Cutaneous Leishmaniasis

  2004cited by this paper
• EFFICACY OF COMBINED TRIPLE THERAPY (PARAMOMYCIN OINTMENT, CRYOTHERAPY AND INTRALESIONAL GLUCANTIME) IN COMPARISON WITH INTRALESIONAL GLUCANTIME FOR THE TREATMENT OF ACUTE CUTANEOUS LEISHMANIASIS

  2004cited by this paper
• Treatment of cutaneous leishmaniasis among travellers.

  2004cited by this paper
• Intention-to-treat

  2004cited by this paper
• Treatment of cutaneous leishmaniasis by intralesional metronidazole.

  2004cited by this paper
• ORAL ZINC SULFATE IN THE TREATMENT OF ACUTE CUTANEOUS LEISHMANIASIS

  2003cited by this paper
• Treatment of cutaneous leishmaniasis with ketoconazole cream

  2003cited by this paper
• Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate

  2003cited by this paper
• TOPICAL TRICHLOROACETIC ACID COMPARED WITH INTRALESIONAL GLUCANTIME INJECTION IN THE TREATMENT OF ACUTE WET CUTANEOUS LEISHMANIASIS: AN OPEN CLINICAL TRIAL

  2003cited by this paper
• A COMPARISON BETWEEN CRYOTHERAPY ALONE AND COMBINED WITH INTRALESIONAL GLUCANTIME INJECTION IN THE TREATMENT OF PAPULONODULAR LEISHMANIASIS

  2003cited by this paper
• The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis

  2003cited by this paper
• Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod

  2003cited by this paper
• Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran.

  2003cited by this paper
• A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel.

  2002cited by this paper
• Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major.

  2002cited by this paper
• Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis

  2002cited by this paper
• Treatment of cutaneous leishmaniasis with a combination of allopurinol and low‐dose meglumine antimoniate

  2002cited by this paper
• Efficacious topical treatment for human cutaneous leishmaniasis with ethanolic lipid amphotericin B.

  2001cited by this paper
• ASSESSMENT OF THE EFFECT OF TOPICAL OPIUM IN TREATMENT OF CUTANEOUS LEISHMANIASIS

  2001cited by this paper
• Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis

  2001cited by this paper
• Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis

  2001cited by this paper
• Leishmaniasis: Current Status of Vaccine Development

  2001cited by this paper
• TREATMENT OF CUTANEOUS LEISHMANIASIS WITH 5% GARLIC CREAM:A RANDOMIZED, DOUBLE-BLIND STUDY

  2000cited by this paper
• The role of rifampicin in the management of cutaneous leishmaniasis.

  2000cited by this paper
• A double‐blind randomized clinical trial of a topical herbal extract (Z‐HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran

  1999cited by this paper
• Leishmaniasis.

  1999cited by this paper
• Topical amphotericin B for cutaneous leishmaniasis.

  1999cited by this paper
• Treatment of cutaneous leishmaniasis with 20% paromomycin ointment

  1999cited by this paper
• Weekly vs. fortnightly intralesional meglumine antimoniate in cutaneous leishmaniasis

  1999cited by this paper
• Intralesional treatment of cutaneous leishmaniasis with meglumine antimoniate

  1998cited by this paper
• Treatment of cutaneous leishmaniasis with itraconazole

  1998cited by this paper
• Interval estimation for the difference between independent proportions: comparison of eleven methods.

  1998cited by this paper
• Treatment of cutaneous antimony: intramuscular administration leishmaniasis with versus intralesional

  1997cited by this paper
• Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration.

  1997cited by this paper
• A comparative controlled trial of intralesionally‐administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis

  1997cited by this paper
• Old World cutaneous leishmaniasis

  1997cited by this paper
• A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey

  1997cited by this paper
• Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years.

  1997cited by this paper
• Treatment of cutaneous leishmaniasis with itraconazole. Randomized double-blind study.

  1996cited by this paper
• Assessing the quality of reports of randomized clinical trials: is blinding necessary?

  1996cited by this paper
• CUTANEOUS LEISHMANIASIS: SCHEDULES FOR INTRALESIONAL TREATMENT WITH SODIUM STIBOGLUCONATE

  1996cited by this paper
• Itraconazole and leishmaniasis: a randomised double-blind trial in cutaneous disease.

  1996cited by this paper
• Cutaneous leishmaniasis: clinical aspect.

  1996cited by this paper
• Treatment of cutaneous leishmaniasis (Old World).

  1996cited by this paper
• TREATMENT OF RECURRENT CUTANEOUS LEISHMANIASIS

  1995cited by this paper
• FAILURE OF KETOCONAZOLE TREATMENT IN CUTANEOUS LEISHMANIASIS

  1995cited by this paper
• A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran.

  1995cited by this paper
• KETOCONAZOLE IN THE TREATMENT OF CUTANEOUS LEISHMANIASIS IN KUWAIT

  1995cited by this paper
• A randomized, double-blind, clinical trial of topical clotrimazole versus miconazole for treatment of cutaneous leishmaniasis in the eastern province of Saudi Arabia.

  1995cited by this paper
• A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment.

  1995cited by this paper
• TREATMENT OF CUTANEOUS LEISHMANIASIS WITH ORAL ITRACONAZOLE

  1994cited by this paper
• Treatment of Cutaneous Leishmaniasis with Oral Itraconazole

  1994cited by this paper
• CLINICAL PICTURE OF CUTANEOUS LEISHMANIASIS IN ISFAHAN, IRAN

  1994cited by this paper
• INTRALESIONAL TREATMENT OF CUTANEOUS LEISHMANIASIS WITH SODIUM STIBOGLUCONATE ANTIMONY

  1993cited by this paper
• Local application of diminazene aceturate: an effective treatment for cutaneous leishmaniasis?

  1992cited by this paper
• Evaluation of topical ketoconazole in cutaneous leishmaniasis.

  1992cited by this paper
• Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study.

  1992cited by this paper
• A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-γ in the local treatment of cutaneous leishmaniasis

  1991cited by this paper
• Cutaneous Leishmaniasis in Kuwait

  1991cited by this paper
• A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-gamma in the local treatment of cutaneous leishmaniasis.

  1991cited by this paper
• A double-blind study on the efficacy of oral dapsone in cutaneous leishmaniasis.

  1991cited by this paper
• Cutaneous Leishmaniasis In India

  1990cited by this paper
• A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment.

  1990cited by this paper
• Dermal Leishmaniasis and Rifampicin

  1989cited by this paper
• Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony

  1988cited by this paper
• Topical application of human fibroblast interferon (IFN) in cutaneous leishmaniasis.

  1987cited by this paper
• Efficacy of Rifampicin and Isoniazid in Cutaneous Leishmaniasis

  1987cited by this paper
• Dapsone in the Treatment of Cutaneous Leishmaniasis

  1986cited by this paper
• Cryotherapy in Acute Cutaneous Leishmaniasis

  1986cited by this paper
• Treatment of Cutaneous Leishmaniasis with Infrared Heat

  1986cited by this paper
• Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride.

  1985cited by this paper
• Combination Therapy of Sodium Stibogluconat and Rifampin in Cutaneous Leishmaniasis

  1984cited by this paper

• The synergistic anti-leishmanial effect of photodynamic therapy employing chemotherapy-mediated nanocomposites

  2025cites this paper
• Erysipeloid Cutaneous Leishmaniasis in the Old World: A Systematic Review.

  2025cites this paper
• Sistemik Antimon ile Tedavi Edilen Kutanöz Leishmaniasis Tanılı Hastaların Klinik Özellikleri ve Tedavi Yanıtları

  2023cites this paper
• Mutual Role of Patients and the Healthcare System in the Control of Cutaneous Leishmaniasis

  2023cites this paper
• The Quest for Understanding Cutaneous Leishmaniasis in Northern Province, Sri Lanka: An Analysis of Clinical Data From the District General Hospital, Vavuniya

  2023cites this paper
• Overexpression of Iron Super Oxide Dismutases A/B Genes Are Associated with Antimony Resistance of Leishmania tropica Clinical Isolates

  2022cites this paper
• Comparing the Efficacy of Monotherapy with Intralesional Meglumine Antimoniate and Combination Therapy with Trichloroacetic Acid 50% and Intralesional Meglumine Antimoniate for the Treatment of Acute Cutaneous Leishmaniasis

  2022cites this paper
• Treatment outcome of imported cutaneous leishmaniasis among travellers and migrants infected with Leishmania major and Leishmania tropica: a retrospective study in European centres 2013 to 2019.

  2022cites this paper
• Biophysical and ultrasonographic changes of acute Old World cutaneous leishmaniasis skin lesions in comparison with uninvolved skin: A possible tool for non‐invasive early detection and treatment outcome assessment

  2022cites this paper
• Efficacy of intra-lesional injections of meglumine antimoniate once a week vs. twice a week in the treatment of cutaneous leishmaniasis caused by L. tropica in Iran: A randomized controlled clinical trial

  2022cites this paper
• Pilot study of safety and efficacy of topical liposomal amphotericin B for cutaneous leishmaniasis caused by Leishmania major in Islamic Republic of Iran.

  2022cites this paper
• sQuiz your knowledge: An ulcerated plaque on the dorsum of the hand

  2021cites this paper
• Antileishmanial effect of silver nanoparticles: Green synthesis, characterization, in vivo and in vitro assessment.

  2021cites this paper
• A Review on Cutaneous Leishmaniasis

  2021cites this paper
• Evaluation of the Photodynamic Therapy with Curcumin on L. braziliensis and L. major Amastigotes

  2021cites this paper
• Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica: study protocol for a randomized, controlled trial

  2021cites this paper
• Preparation and characterization of amphotericin B mannosylated liposomes for effective management of visceral leishmaniasis

  2021cites this paper
• Assessing the compliance of systematic review articles published in leading dermatology journals with the PRISMA statement guidelines: A systematic review

  2020cites this paper
• Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients

  2020cites this paper
• Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice

  2020cites this paper
• A review of current treatments strategies based on paromomycin for leishmaniasis

  2020cites this paper
• Searching drugs for Chagas disease, leishmaniasis and schistosomiasis: a brief review.

  2020cites this paper
• Patients’ preferences of cutaneous leishmaniasis treatment outcomes: Findings from an international qualitative study

  2020cites this paper
• Clinical and Epidemiological study of Cutaneous Leishmaniasis from two tertiary care hospitals of Jammu and Kashmir: an Emerging Disease in North India.

  2020cites this paper
• Sugar-Based Colloidal Nanocarriers for Topical Meglumine Antimoniate Application to Cutaneous Leishmaniasis Treatment: Ex vivo Cutaneous Retention and In vivo Evaluation.

  2020cites this paper
• Cutaneous leishmaniasis: A neglected disfiguring disease for women

  2019influential citation
• Safety Evaluation of Topical Application of Nano-Liposomal Form of Amphotericin B (SinaAmpholeish) on Healthy Volunteers: Phase I Clinical Trial

  2019cites this paper
• Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran

  2019cites this paper
• Clinical and laboratory evaluation of cured and non-cured patients with cutaneous leishmaniasis treated by Glucantime.

  2019cites this paper
• Leishmanicidal Effects of Allium giganteum Saponin-Rich Fraction on Leishmania major

  2019cites this paper
• Old world cutaneous leishmaniasis in Iran: clinical variants and treatments

  2019cites this paper
• Efficacy of erbium glass laser in the treatment of Old World cutaneous leishmaniasis: A case series

  2019cites this paper
• Tioxolone niosomes exert antileishmanial effects on Leishmania tropica by promoting promastigote apoptosis and immunomodulation

  2019cites this paper
• Leishmaniasis cutánea, a propósito de un caso.

  2019influential citation
• Ex vivo and in vitro studies on Toll like receptors in canine Leishmania infection

  2018cites this paper
• Treatment of tegumentary forms of leishmaniasis

  2018cites this paper
• Leishmaniasis treatment: update of possibilities for drug repurposing.

  2018cites this paper
• Prevalence of skin diseases of the pediatric population in the Southeastern Anatolia, Turkey -

  2018cites this paper
• Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis

  2018cites this paper
• Travelers’ tropical skin diseases: Challenges and interventions

  2018cites this paper
• It is on my skin, on my soul, and on my life : development of a disease-specific quality of life instrument for adult patients with acute cutaneous leishmaniasis in Iran

  2018influential citation
• Lived Experiences of Patients Suffering from Acute Old World Cutaneous Leishmaniasis: A Qualitative Content Analysis Study from Iran

  2018cites this paper
• Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey

  2018cites this paper
• Effect of Azithromycin in Treatment of Cutaneous Leishmaniasis

  2018cites this paper
• Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis

  2017cites this paper
• Efficacy of cryotherapy plus topical Juniperus excelsa M. Bieb cream versus cryotherapy plus placebo in the treatment of Old World cutaneous leishmaniasis: A triple-blind randomized controlled clinical trial

  2017cites this paper
• Network analysis to support public health: evolution of collaboration among leishmaniasis researchers

  2017cites this paper
• Interventions for Old World cutaneous leishmaniasis.

  2017cites this paper
• Liposomal adjuvant development for leishmaniasis vaccines

  2017cites this paper
• Cutaneous leishmaniasis and its clinical spectrum. An overview from the Old World

  2017cites this paper
• Interventions for Old World cutaneous leishmaniasis.

  2017cites this paper
• Interventions for Old World cutaneous leishmaniasis.

  2017cites this paper
• EVALUATION OF THE CUTANEOUES LEISHMANIASIS TREATMENT IN AL-MERGHEB, LIBYA

  2017cites this paper
• A novel non-invasive diagnostic sampling technique for cutaneous leishmaniasis

  2017cites this paper
• Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis

  2016cites this paper
• The role of GlcNAc-PI-de-N-acetylase gene by gene knockout through homologous recombination and its consequences on survival, growth and infectivity of Leishmania major in in vitro and in vivo conditions.

  2016cites this paper
• Therapeutic and adverse effects of standard- dose and low-dose meglumine antimoniate during systemic treatment of Syrian cutaneous leishmaniasis patients

  2016cites this paper
• Treatment of Acute Cutaneous Leishmaniasis by Oral Zinc Sulfate and Oral Ketocanazole Singly and in Combination

  2016cites this paper
• Electrocardiographic and biochemical adverse effects of meglumine antimoniate (MA) during treatment of Syrian cutaneous leishmaniasis patients

  2016cites this paper
• A critical review of evidence-based medicine: The need for moving toward real evidence-based medicine

  2016cites this paper
• Clinical audit: Baseline investigations for intramuscular meglumine antimoniate in cases of cutaneous leishmaniasis

  2016cites this paper
• Comparison of the efficacy of intralesional versus intramuscular injection Meglumine Antimoniate in the treatment of sores of Cutaneous Leishmaniasis

  2016cites this paper
• Designing and Cloning Molecular Constructs to Knock Out N-Acetylglucosamine Phosphatidylinositol De-N-Acetylase (GPI12) Gene in Leishmania major (MRHO/IR/75/ER)

  2016cites this paper
• Pediatric Cutaneous Leishmaniasis in an Endemic Region in Turkey: A Retrospective Analysis of 8786 Cases during 1998-2014

  2016cites this paper
• Intralesional 8.33% Rifamycin infiltration; New treatment for cutaneous leishmaniasis

  2016cites this paper
• The Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi Infection

  2015cites this paper
• Magnesium oxide nanoparticles coated with glucose can silence important genes of Leishmania major at sub-toxic concentrations.

  2015cites this paper
• Clinical study of cutaneous leishmaniasis in the Kashmir Valley

  2015influential citation
• Treatment of cutaneous leishmaniasis by topical 25% podophyllin solution (single, blinded, therapeutic, controlled study)

  2015cites this paper
• he role of GlcNAc-PI-deN-acetylase gene by gene knockout through omologous recombination and its consequences on survival , growth nd infectivity of Leishmania major in in vitro and in vivo conditions ooya

  2015cites this paper
• Comparison of Lesion Improvement in Lupoid Leishmaniasis Patients with Two Treatment Approaches

  2015cites this paper
• [Investigation and analysis of an outbreak of cutaneous leishmaniasis in Ksar Ouled Dabbab, Tataouine (Tunisia), 2012-2013].

  2015cites this paper
• A cutaneous leishmania case left a deep scar on the face and delayed at diagnosis

  2015cites this paper
• Cutaneous leishmaniasis in Syria: clinical features, current status and the effects of war.

  2015cites this paper
• Bioactive Neolignans from the Leaves of Piper rivinoides Kunth ( Piperaceae )

  2015cites this paper
• Cutaneous Leishmaniasis in Middle East and North Africa

  2014cites this paper
• Comment on: S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.

  2014cites this paper
• LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014.

  2014cites this paper
• Leishmaniasis in travelers: a literature review.

  2014cites this paper
• Cutaneous Leishmaniasis in Iraq : A clinicoepidemiological descriptive study

  2014cites this paper
• Comparison Between Intralesional Meglumine Antimoniate and Combination of Trichloroacetic Acid 50% and Intralesional Meglumine Antimoniate in the Treatment of Acute Cutaneous Leishmaniasis: A Randomized Clinical Trial

  2014cites this paper
• Anti-leishmanial Activity of Gossypium hirsutum L., Ferula assa-foetida L. and Artemisia aucheri Boiss. Extracts by Colorimetric Assay

  2014cites this paper
• Comparative Analysis of the Omics Technologies Used to Study Antimonial, Amphotericin B, and Pentamidine Resistance in Leishmania

  2014cites this paper
• Immunoliposomes containing Soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis.

  2014cites this paper
• Therapeutic Effect of Hedera helix Alcoholic Extract Against Cutaneous Leishmaniasis Caused by Leishmania major in Balb/c Mice

  2014influential citation
• TLR2 and TLR4 in Cutaneous Leishmaniasis Caused by Leishmania major

  2013cites this paper
• Dressings Combined with Injection of Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis: A Randomized Controlled Clinical Trial

  2013cites this paper
• S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.

  2013cites this paper
• Travelers with cutaneous leishmaniasis cured without systemic therapy.

  2013cites this paper
• Cutaneous Leishmaniasis in Suspected Patients Referred To the Center for Research and Training in Skin Diseases and Leprosy, Tehran, Iran from 2008 To 2011

  2013cites this paper
• Molecular characterization of Leishmania infection in sand flies from Al-madinah Al-munawarah province, western Saudi Arabia.

  2013cites this paper
• Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach.

  2013cites this paper
• Local Treatments for Cutaneous Leishmaniasis

  2013cites this paper
• Antiparasitic effects of gold nanoparticles with microwave radiation on promastigotes and amastigotes of Leishmania major

  2013cites this paper
• Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends.

  2013cites this paper
• Development of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasis

  2013cites this paper
• A case of cutaneous leishmaniasis found in Indiana.

  2013influential citation
• Editorial commentary: local treatments for cutaneous leishmaniasis.

  2013cites this paper
• Cluster of zoonotic cutaneous leishmaniasis (Leishmania major) in European travelers returning from Turkmenistan.

  2013cites this paper
• Electrocardiographic and Biochemical Adverse Effects of Meglumine Antimoniate During the Treatment of Syrian Cutaneous Leishmaniasis Patients

  2013cites this paper